Andrew J. Kurtz PhD

Dr. Kurtz has been a Program Director in the Small Business Innovation Research Development Center at the National Cancer Institute. His management portfolio includes projects focused on early-stage cancer drug development, including small molecules, biologics, and novel multifunctional therapeutics based on nanotechnology. Previously, Dr. Kurtz was an AAAS Science and Technology Policy Fellow at the NIH, during which time he served on the management team of The Cancer Genome Atlas Pilot Project. Dr. Kurtz received a PhD in Biochemistry & Molecular Biology from The University of Texas Medical Branch at Galveston.